Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Invested Capital (2016 - 2025)

Historic Invested Capital for Lexaria Bioscience (LEXX) over the last 15 years, with Q4 2025 value amounting to $4.9 million.

  • Lexaria Bioscience's Invested Capital fell 4770.21% to $4.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.9 million, marking a year-over-year decrease of 4770.21%. This contributed to the annual value of $3.0 million for FY2025, which is 6096.52% down from last year.
  • As of Q4 2025, Lexaria Bioscience's Invested Capital stood at $4.9 million, which was down 4770.21% from $3.0 million recorded in Q3 2025.
  • Lexaria Bioscience's 5-year Invested Capital high stood at $13.1 million for Q3 2021, and its period low was $2.7 million during Q3 2023.
  • Its 5-year average for Invested Capital is $7.5 million, with a median of $7.4 million in 2022.
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 51883.34% in 2021, then tumbled by 6488.59% in 2023.
  • Quarter analysis of 5 years shows Lexaria Bioscience's Invested Capital stood at $11.5 million in 2021, then crashed by 45.86% to $6.2 million in 2022, then plummeted by 41.63% to $3.6 million in 2023, then skyrocketed by 159.02% to $9.4 million in 2024, then plummeted by 47.7% to $4.9 million in 2025.
  • Its last three reported values are $4.9 million in Q4 2025, $3.0 million for Q3 2025, and $5.6 million during Q2 2025.